Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity

The design and development of new pharmaceutical formulations for the existing anti-leishmanial is a new strategic alternate to improve efficacy and safety rather than new drug discovery. Herein hybrid solid lipid nanoparticles (SLN) have been engineered to direct the oral delivery of two anti-leish...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvez, Shabi, Yadagiri, Ganesh, Karole, Archana, Singh, Om Prakash, Verma, Anurag, Sundar, Shyam, Mudavath, Shyam Lal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593694/
https://www.ncbi.nlm.nih.gov/pubmed/33178626
http://dx.doi.org/10.3389/fcimb.2020.570573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593694/
https://www.ncbi.nlm.nih.gov/pubmed/33178626
http://dx.doi.org/10.3389/fcimb.2020.570573

Ejemplares similares